Brattleboro Retreat May Close or Be Sold Due to Financial Crisis

Vermont’s largest in-patient mental health facility, the Brattleboro Retreat, has voted to begin the process of either closing or selling the facility due to financial troubles. Vermont Human Services Secretary Mike Smith says the state has invested millions of dollars into the privately run facility but says management “has failed to deliver fiscal stability to

Brattleboro Retreat May Close or Be Sold Due to Financial Crisis Read More »

Part of DeGraff Hospital Is up for Sale

Among the many changes coming to DeGraff Hospital this year, part of it is now up for sale. The five-story main hospital tower on 445 Tremont Street will be re-used as a redevelopment opportunity, per Kaleida Health. Pyramid Brokerage Company is looking to sell the 85,000-sqaure-foot building in North Tonawanda for for multi-family redevelopment or

Part of DeGraff Hospital Is up for Sale Read More »

Doctors and Hospitals Support Value-Based Stark Law Changes

Doctors and hospitals have voiced support for the Trump administration’s efforts to encourage value-based care by reforming physician self-referral rules, but they oppose including any sort of price transparency requirements. The CMS wants to change Stark law regulations to make it easier for providers to enter into value-based arrangements without running afoul of kickback concerns.

Doctors and Hospitals Support Value-Based Stark Law Changes Read More »

Foot and Ankle Specialists of the Mid-Atlantic Extends to Gastonia, NC

Foot and Ankle Specialists of the Mid-Atlantic (FASMA) has expanded in North Carolina with its newest division in Gastonia, NC, with the joining of Gaston Foot & Ankle Associates on December 1, 2019. With the partnership of the office in Gastonia, FASMA will function in 42 locations across DC, Maryland, Pennsylvania, Virginia, and North Carolina

Foot and Ankle Specialists of the Mid-Atlantic Extends to Gastonia, NC Read More »

Melinta Therapeutics Announces Restructuring Support Agreement with Its Secured Lenders under Its Senior Credit Facility

Melinta Therapeutics, Inc. (NASDAQ: MLNT) (the “Company” or “Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, announced that it has entered into a Restructuring Support Agreement (the “Agreement”) with the lenders under its senior credit facility, Deerfield Private Design Fund III, L.P. and Deerfield Private

Melinta Therapeutics Announces Restructuring Support Agreement with Its Secured Lenders under Its Senior Credit Facility Read More »

Urovant Sciences Majority Shareholder, Roivant Sciences, and Sumitomo Dainippon Pharma Complete Transaction for Strategic Alliance

Urovant Sciences (Nasdaq: UROV) (“Urovant”) announced that its majority shareholder, Roivant Sciences Ltd. (“Roivant”), and Sumitomo Dainippon Pharma Co., Ltd. (TSE: 4506) (“Sumitomo Dainippon Pharma”), a leading global Japanese pharmaceutical company, have completed their transaction that creates a significant, multinational Sumitomo Dainippon Pharma-Roivant Alliance (“Alliance”), including the transfer of Roivant’s ownership interests in Urovant, as

Urovant Sciences Majority Shareholder, Roivant Sciences, and Sumitomo Dainippon Pharma Complete Transaction for Strategic Alliance Read More »

Scroll to Top